Haase, Volker H.

HIF-1α is essential for myeloid cell-mediated inflammation

Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell

Cancer, Hypoxia, and MetabolismImmune cells in cancer

Cited by 2,046

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 976

Regulation of erythropoiesis by hypoxia-inducible factors

Haase, V. H. (2013) · Blood Reviews

Erythropoietin and Anemia TreatmentHigh Altitude and Hypoxia

Cited by 787

Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis

Karhausen, J., Furuta, G. T., Tomaszewski, J. E., Johnson, R. S., Colgan, S. P., & Haase, V. H. (2004) · Journal of Clinical Investigation

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 655

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)

Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 639

Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo

Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2007) · Journal of Clinical Investigation

Erythropoietin and Anemia TreatmentCancer, Hypoxia, and Metabolism

Cited by 596

Hypoxic regulation of erythropoiesis and iron metabolism

Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology

Erythropoietin and Anemia TreatmentHemoglobin structure and function

Cited by 347

Hypoxia-inducible factor 2 regulates hepatic lipid metabolism

Rankin, E. B., Rha, J., Selak, M. A., Unger, T. L., Keith, B., Liu, Q., & Haase, V. H. (2009) · Molecular and Cellular Biology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 338

Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis

Liu, Q., Davidoff, O., Niss, K., & Haase, V. H. (2012) · Journal of Clinical Investigation

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 328

Anaemia in kidney disease: harnessing hypoxia responses for therapy

Koury, M. J., & Haase, V. H. (2015) · Nature Reviews Nephrology

Erythropoietin and Anemia TreatmentIron Metabolism and Disorders

Cited by 313

Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia

Kapitsinou, P. P., Liu, Q., Unger, T. L., Rha, J., Davidoff, O., Keith, B., Epstein, J. A., Moores, S. L., Erickson-Miller, C. L., & Haase, V. H. (2010) · Blood

Erythropoietin and Anemia TreatmentHemoglobin structure and function

Cited by 307

The VHL tumor suppressor: master regulator of HIF

Haase, V. (2009) · Current Pharmaceutical Design

Cancer, Hypoxia, and MetabolismEar and Head Tumors

Cited by 175

Hypoxia-Inducible Factor Augments Experimental Colitis Through an MIF–Dependent Inflammatory Signaling Cascade

Shah, Y. M., Ito, S., Morimura, K., Chen, C., Yim, S., Haase, V. H., & Gonzalez, F. J. (2008) · Gastroenterology

Inflammatory Bowel DiseaseMacrophage Migration Inhibitory Factor

Cited by 168

The VHL tumor suppressor and HIF: insights from genetic studies in mice

Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation

Cancer, Hypoxia, and MetabolismEar and Head Tumors

Cited by 151

Hypoxia inducible factor 1α regulates T cell receptor signal transduction

Neumann, A. K., Yang, J., Biju, M. P., Joseph, S. K., Johnson, R. S., Haase, V. H., Freedman, B. D., & Turka, L. A. (2005) · Proceedings of the National Academy of Sciences

Cancer, Hypoxia, and MetabolismT-cell and B-cell Immunology

Cited by 120

Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease

Haase, V. H., Tanaka, T., & Koury, M. J. (2024) · Hematology

Erythropoietin and Anemia TreatmentIron Metabolism and Disorders

Cited by 19